Furthermore, our work highlights that CRC expressing these NRP1 splice variants could potentially be targeted by blocking endocytosis of them and their binding receptors such as Met or β1-integrin, or their endosomal signals on activation of the FAK/p130Cas pathway. This evidence concerns the gene MET and colorectal carcinoma.